{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:39:01Z","timestamp":1788979141658,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"crossref","award":["PRG2218"],"award-info":[{"award-number":["PRG2218"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"crossref","award":["PRG2218"],"award-info":[{"award-number":["PRG2218"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"crossref","award":["PRG2218"],"award-info":[{"award-number":["PRG2218"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Child Adolesc Psychiatry Ment Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The COVID-19 pandemic has posed challenges that worsened people\u2019s mental health. We explored the impact of the COVID-19 pandemic on the mental well-being of the population, as indicated by the prevalence rates of benzodiazepine and benzodiazepine-related drug (BDZ) use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This population\u2010based, time\u2010series analysis included all prescriptions of BDZs dispensed in Estonia between 2012 and 2021. The monthly prevalence rates of BDZ use were calculated. Autoregressive integrated moving average models with pulse and slope intervention functions tested for temporary and long-term changes in monthly prevalence rates after the onset of the COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Throughout the 10-year study period, a total of 5,528,911 BDZ prescriptions were dispensed to 397,436 individuals. A significant temporary increase in the overall prevalence rate of BDZ use in March 2020 (2.698 users per 1000, 95% CI 1.408\u20133.988) was observed, but there was no statistically significant long-term change. This temporary increase affected all the examined subgroups, except for new users, individuals aged 15\u201329\u00a0years, and prescribing specialists other than general practitioners and psychiatrists. The long-term increase in BDZ use was confined to females aged 15\u201329\u00a0years (0.056 users per 1000 per month, 95% CI 0.033\u20130.079), while no significant change was observed among males of the same age (0.009 users per 1000 per month, 95% CI \u2013\u00a00.017 to 0.035). Among females aged 15\u201329\u00a0years, a significant long-term increase in BDZ use was observed for anxiety disorders (0.017 users per 1000 per month, 95% CI 0.010\u20130.023), depressive disorders (0.021 users per 1000 per month, 95% CI 0.012\u20130.030), and other mental and behavioral disorders (0.020 users per 1000 per month, 95% CI 0.010\u20130.030), but not for sleep disorders (\u2013\u00a00.008 users per 1000 per month, 95% CI \u2013\u00a00.018\u20130.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The COVID-19 pandemic led to a short-term increase in BDZ use immediately after the pandemic was declared. In the long term, young females experienced a sustained increase in BDZ use. The prolonged effect on girls and young women suggests their greater vulnerability. These results underscore the need to effectively address the long-term effects of the pandemic among youth.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13034-024-00757-5","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T13:01:50Z","timestamp":1717678910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The COVID-19 pandemic and the use of benzodiazepines and benzodiazepine-related drugs in Estonia: an interrupted time-series analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Katrin","family":"Kurvits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Toompere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peeter","family":"Jaanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Uusk\u00fcla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"issue":"32","key":"757_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","volume":"69","author":"M\u00c9 Czeisler","year":"2022","unstructured":"Czeisler M\u00c9, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic: United States, June 24\u201330, 2020. MMWR Morb Mortal Wkly Rep. 2022;69(32):1049\u201357.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"757_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S2215-0366(20)30308-4","volume":"7","author":"M Pierce","year":"2020","unstructured":"Pierce M, Hope H, Ford T, Hatch S, Hotopf M, John A, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry. 2020;7(10):883\u201392.","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"757_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2215-0366(23)00113-X","volume":"10","author":"N Ahmed","year":"2023","unstructured":"Ahmed N, Barnett P, Greenburgh A, Pemovska T, Stefanidou T, Lyons N, et al. Mental health in Europe during the COVID-19 pandemic: a systematic review. Lancet Psychiatry. 2023;10(7):537\u201356.","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"757_CR4","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited: will we ever learn? Addiction. 2011;106(12):2086\u2013109.","journal-title":"Addiction"},{"key":"757_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109176","volume":"229","author":"C de Dios","year":"2021","unstructured":"de Dios C, Fernandes BS, Whalen K, Bandewar S, Suchting R, Weaver MF, et al. Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2021;229: 109176.","journal-title":"Drug Alcohol Depend"},{"key":"757_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108486","volume":"219","author":"CM Jones","year":"2021","unstructured":"Jones CM, Guy GP, Board A. Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020. Drug Alcohol Depend. 2021;219: 108486.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"757_CR7","doi-asserted-by":"publisher","first-page":"e2131012","DOI":"10.1001\/jamanetworkopen.2021.31012","volume":"4","author":"SA Milani","year":"2021","unstructured":"Milani SA, Raji MA, Chen L, Kuo YF. Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among US women and men before and during the COVID-19 pandemic. JAMA Netw Open. 2021;4(10):e2131012\u2013e2131012.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"757_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/da.23228","volume":"39","author":"S Uthayakumar","year":"2022","unstructured":"Uthayakumar S, Tadrous M, Vigod SN, Kitchen SA, Gomes T. The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada. Depress Anxiety. 2022;39(2):156\u201362.","journal-title":"Depress Anxiety"},{"issue":"8","key":"757_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18441","volume":"4","author":"MA Campitelli","year":"2021","unstructured":"Campitelli MA, Bronskill SE, Maclagan LC, Harris DA, Cotton CA, Tadrous M, et al. Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada. JAMA Netw Open. 2021;4(8): e2118441.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"757_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40266-022-00948-9","volume":"39","author":"A Ferro Uriguen","year":"2022","unstructured":"Ferro Uriguen A, Laso Lucas E, Sannino Menicucci C, Iturrioz Arrechea I, Alaba Trueba J, Echevarr\u00eda Orella E, et al. Psychotropic drug prescription in nursing homes during the COVID-19 pandemic. Drugs Aging. 2022;39(6):467\u201375.","journal-title":"Drugs Aging"},{"key":"757_CR11","unstructured":"Tervisekassa. Andmep\u00e4ringud. https:\/\/www.tervisekassa.ee\/andmeparingud. Accessed 28 Aug 2023."},{"key":"757_CR12","unstructured":"Statistics Estonia. Statistical database. Population figure and composition. https:\/\/andmed.stat.ee\/et\/stat. Accessed 28 Oct 2022."},{"key":"757_CR13","unstructured":"Riigi Teataja I. Ravimite v\u00e4ljakirjutamise ja apteekidest v\u00e4ljastamise tingimused ja kord ning retsepti vorm (26.05.2023). https:\/\/www.riigiteataja.ee\/akt\/123052023039. Accessed 28 Oct 2023"},{"issue":"1","key":"757_CR14","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"757_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-021-01235-8","volume":"21","author":"AL Schaffer","year":"2021","unstructured":"Schaffer AL, Dobbins TA, Pearson SA. Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol. 2021;21(1):1\u201312.","journal-title":"BMC Med Res Methodol"},{"key":"757_CR16","unstructured":"RStudio, PBC, Boston, MA. RStudio Team (2021). RStudio: Integrated Development for R. https:\/\/www.rstudio.com\/."},{"issue":"4","key":"757_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/eurpub\/cky270","volume":"29","author":"LCJ Slobbe","year":"2019","unstructured":"Slobbe LCJ, F\u00fcssenich K, Wong A, Boshuizen HC, Nielen MMJ, Polder JJ, et al. Estimating disease prevalence from drug utilization data using the Random Forest algorithm. Eur J Public Health. 2019;29(4):615.","journal-title":"Eur J Public Health"},{"key":"757_CR18","unstructured":"Tervise Arengu Instituut. Eesti rahvastiku vaimse tervise uuring. L\u00f5pparuanne, 2022. https:\/\/tai.ee\/et\/valjaanded\/eesti-rahvastiku-vaimse-tervise-uuring-lopparuanne."},{"issue":"11","key":"757_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044617","volume":"10","author":"C Jacques-Avin\u00f5","year":"2020","unstructured":"Jacques-Avin\u00f5 C, L\u00f3pez-Jim\u00e9nez T, Medina-Perucha L, De Bont J, Gonc\u0105lves AQ, Duarte-Salles T, et al. Gender-based approach on the social impact and mental health in Spain during COVID-19 lockdown: a cross-sectional study. BMJ Open. 2020;10(11): e044617.","journal-title":"BMJ Open"},{"issue":"2","key":"757_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2022.4165","volume":"80","author":"M Bliddal","year":"2023","unstructured":"Bliddal M, Rasmussen L, Andersen JH, Jensen PB, Potteg\u00e5rd A, Munk-Olsen T, et al. Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among Danish children, adolescents, and young adults. JAMA Psychiat. 2023;80(2):176\u201380.","journal-title":"JAMA Psychiat"},{"issue":"11","key":"757_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamapediatrics.2021.2482","volume":"175","author":"N Racine","year":"2021","unstructured":"Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175(11):1142\u201350.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"757_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13034-023-00612-z","volume":"17","author":"H Ludwig-Walz","year":"2023","unstructured":"Ludwig-Walz H, Dannheim I, Pfadenhauer LM, Fegert JM, Bujard M. Anxiety increased among children and adolescents during pandemic-related school closures in Europe: a systematic review and meta-analysis. Child Adolesc Psychiatry Ment Health. 2023;17(1):1\u201319.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"757_CR23","unstructured":"OECD. School closure during COVID-19. https:\/\/www.oecd.org\/coronavirus\/en\/data-insights\/school-closure-during-covid-19. Accessed 30 Mar 2024."},{"key":"757_CR24","first-page":"1","volume-title":"Successful aging: perspectives from the behavioral sciences","year":"1990","unstructured":"Baltes PB, Baltes MM, editors. Successful aging: perspectives from the behavioral sciences. Cambridge, UK: Cambridge University Press; 1990. p. 1\u201334."},{"key":"757_CR25","unstructured":"OECD. Waiting Times for Health Services: Next in Line. OECD Health Policy Studies. Paris, 2020. https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/waiting-times-for-health-services_242e3c8c-en."},{"key":"757_CR26","unstructured":"National Audit Office. Audit report: Healthcare trends in Estonia. Tallinn, 2022. https:\/\/www.riigikontroll.ee\/Suhtedavalikkusega\/Pressiteated\/tabid\/168\/ItemId\/2378\/amid\/557\/language\/en-US\/Default.aspx."},{"issue":"1","key":"757_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.healthpol.2018.10.002","volume":"123","author":"K P\u00f5lluste","year":"2019","unstructured":"P\u00f5lluste K, Kosunen E, Koskela T, Mattila KJ, Sch\u00e4fer WLA, Boerma WGW, et al. Primary health care in transition: Variations in service profiles of general practitioners in Estonia and in Finland between 1993 and 2012. Health Policy. 2019;123(1):37\u201344.","journal-title":"Health Policy"},{"issue":"1","key":"757_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-7-64","volume":"7","author":"P \u00d6\u00f6pik","year":"2006","unstructured":"\u00d6\u00f6pik P, Aluoja A, Kalda R, Maaroos HI. Family doctors\u2019 problems and motivating factors in management of depression. BMC Fam Pract. 2006;7(1):1\u20136.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"757_CR29","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798.","journal-title":"Int J Epidemiol"},{"issue":"7107","key":"757_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/bmj.315.7107.520","volume":"315","author":"J Cockburn","year":"1997","unstructured":"Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients\u2019 expectations and doctors\u2019 perceptions of patients\u2019 expectations\u2013a questionnaire study. BMJ: Br Med J. 1997;315(7107):520.","journal-title":"BMJ: Br Med J"},{"issue":"1","key":"757_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7954-8-25","volume":"8","author":"RE Cossman","year":"2010","unstructured":"Cossman RE, Cossman JS, James WL, Blanchard T, Thomas R, Pol LG, et al. Correlating pharmaceutical data with a national health survey as a proxy for estimating rural population health. Popul Health Metr. 2010;8(1):1\u201317.","journal-title":"Popul Health Metr"},{"issue":"6","key":"757_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07260","volume":"7","author":"A Mirahmadizadeh","year":"2021","unstructured":"Mirahmadizadeh A, Banihashemi SA, Hashemi M, Amiri S, Basir S, Heiran A, et al. Estimating the prevalence and incidence of treated type 2 diabetes using prescription data as a proxy: a stepwise approach on Iranian data. Heliyon. 2021;7(6): e07260.","journal-title":"Heliyon"},{"key":"757_CR33","doi-asserted-by":"publisher","DOI":"10.3205\/000218","author":"H Richter","year":"2015","unstructured":"Richter H, Dombrowski S, Hamer H, Hadji P, Kostev K. Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology. GMS Ger Med Sci. 2015. https:\/\/doi.org\/10.3205\/000218.","journal-title":"GMS Ger Med Sci"},{"key":"757_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10754-4","author":"K F\u00fcssenich","year":"2021","unstructured":"F\u00fcssenich K, Boshuizen HC, Nielen MMJ, Buskens E, Feenstra TL. Mapping chronic disease prevalence based on medication use and socio-demographic variables: an application of LASSO on administrative data sources in healthcare in the Netherlands. BMC Public Health. 2021. https:\/\/doi.org\/10.1186\/s12889-021-10754-4.","journal-title":"BMC Public Health"},{"issue":"3","key":"757_CR35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/aje\/kwh038","volume":"159","author":"DM Boudreau","year":"2004","unstructured":"Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol. 2004;159(3):308\u201317.","journal-title":"Am J Epidemiol"}],"container-title":["Child and Adolescent Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13034-024-00757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13034-024-00757-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13034-024-00757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T13:05:30Z","timestamp":1717679130000},"score":1,"resource":{"primary":{"URL":"https:\/\/capmh.biomedcentral.com\/articles\/10.1186\/s13034-024-00757-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1186\/s13034-024-00757-5","relation":{},"ISSN":["1753-2000"],"issn-type":[{"value":"1753-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"13 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted from Tartu University Research Ethics Committee (reference number 356\/T-9).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}